| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 12 buys and 1 sell. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.28M | -119,250 | |
| Other | 755.5K | $4.06M | -29,131 | |
| Dir | 613.6K | $3.30M | - | |
| CFO | 554.5K | $2.98M | -41,884 | |
| COO | 497.8K | $2.68M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 18, 2018 | Sabzevari Helen75 | President, Precigen, Inc. | Sale+OE | 8,402 | $14.54 | $122,165.08 | -33.6% | |
| Jul 3, 2018 | Kirk Randal J | Chief Executive Officer | Buy | 7,479,431 | $13.37 | $99,999,992.47 | +33.1% | |
| Jan 19, 2018 | Kirk Randal J | Chief Executive Officer | Buy | 1,000,000 | $12.50 | $12,500,000.00 | +14.7% | |
| Jan 17, 2018 | Kirk Randal J | 10% Owner | Buy | 1,538,461 | $3.25 | $4,999,998.25 | +29.8% | |
| Dec 11, 2017 | Kirk Randal J | 10% Owner | Buy | 2,727,273 | $0.77 | $2,100,000.21 | +80.1% | |
| Nov 13, 2017 | Last Andrew J.49 | Chief Operating Officer | Buy | 2,000 | $12.10 | $24,200.00 | +100.0% | |
| Aug 22, 2017 | Gupta Vinita D | Director | Buy | 3,000 | $17.61 | $52,830.00 | New | |
| Aug 22, 2017 | Shapiro Robert B | Director | Buy | 2,850 | $17.50 | $49,882.98 | +3.6% | |
| Aug 14, 2017 | Last Andrew J.49 | Chief Operating Officer | Buy | 2,000 | $19.99 | $39,980.00 | New | |
| Aug 11, 2017 | Kirk Randal J | Chief Executive Officer | Buy | 132,625 | $18.85 | $2,499,981.25 | +2.0% |